US Preventive Services Task Force (USPSTF)
|
Resource Development
|
AHRQ
|
OD/DPCPSI/ODP, NCI
|
The U.S. Preventive Services Task Force (USPSTF) is an independent panel of non-Federal experts in prevention and evidence-based medicine and is composed of primary care providers. The USPSTF conducts scientific evidence reviews of a broad range of clinical preventive health care services (such as screening, counseling, and preventive medications) and develops recommendations for primary care clinicians and health systems that are published in the form of "Recommendation Statements."
The Agency for Healthcare Research and Quality (AHRQ) has been authorized by the U.S. Congress to convene the Task Force and to provide ongoing scientific, administrative, and dissemination support to the Task Force. The NIH Office of Disease Prevention (ODP) works closely with AHRQ and the USPSTF to provide scientific input from NIH Institutes and Centers on draft research plans, draft evidence reviews, and clinical practice guidelines to be included in the Guide to Clinical Preventive Services. The ODP also disseminates information to NIH Institutes and Centers about high-priority evidence gaps for clinical preventive services that have been identified by the USPSTF.
|
US Public Health Service (USPHS) Physicians Professional Advisory Committee (PPAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA
|
NIAID
|
The purpose of this committee is to provide advice and consultation to the Surgeon General on issues relating to the professional practice and personnel activities, civil service, and Commissioned Corps of the Medical Category.
Provides advisory assistance to the Chief Professional Officer and to the Agency and/or Program Heads of the USPHS and to non-PHS programs that routinely use USPHS personnel.
|
Value Set Authority Center (VSAC)
|
Resource Development
|
AHRQ, CDC, CMS, OS
|
NLM
|
The National Library of Medicine (NLM) provides an online repository of value sets (code sets from standardized medical vocabularies) that are used for clinical quality measurement in the CMS EHR Incentive Program (meaningful use). The Value Set Authority Center (VSAC) provides downloadable access to all official versions of vocabulary value sets contained in the 2014 Clinical Quality Measures (CQMs). Each value set consists of the numerical values (codes) and human-readable names (terms), drawn from standard vocabularies such as SNOMED CT® , RxNorm, LOINC and ICD-10-CM, which are used to define clinical concepts used in clinical quality measures (e.g., patients with diabetes, clinical visit).
|
Violence Against Women Steering Committee (DHHS VAW)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, HRSA, IHS, OS, SAMHSA
|
OD/DPCPSI/ORWH, NIA, NIAAA, NICHD, NIDA, NIMH, NLM, OD/DPCPSI, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR
|
The DHHS Violence Against Women Act (VAWA) steering committee is chaired by the Office on Women’s Health (OWH). The VAWA committee has the responsibility for coordinating the Department of Health and Human Services (DHHS) response to issues related to violence against women and their children, and also coordinates DHHS violence related activities with those of other Federal agencies. The members of the committee establish links with professional societies in the health and social service fields to increase attention to women’s health and violence issues. The members of the committee also serve as resource experts for the National Advisory Committee on VAW, which is chaired by the HHS Secretary and the DOJ Attorney General.
|
Viral Hepatitis Implementation Group
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIDDK, NIDA
|
Building on the success of the nation’s first comprehensive cross-agency action plan, released in 2011, the U.S. Departments of Health and Human Services (HHS), Housing and Urban Development (HUD), Justice (DOJ), and Veterans Affairs (VA) released a 3-year update of the plan in April 2014. The updated Viral Hepatitis Action Plan builds on the foundation of and momentum generated by the original action plan and seeks to harness: new recommendations for health care providers regarding screening for hepatitis C; promising new developments in treatments for hepatitis C; mounting public awareness of and concern about hepatitis B and hepatitis C; and the expansion of access to viral hepatitis prevention, diagnosis, care, and treatment offered by the Affordable Care Act.
|
Vitamin D Standardization Program (VDSP)
|
Research Initiative
|
CDC
|
OD/OSP, OD/DPCPSI/ODS
|
The NIH Office of Dietary Supplements (ODS) collaborates with CDC and others on the VDSP, which is an international collaborative effort to standardize the laboratory measurement of vitamin D status. The goal of the program is to improve the detection, evaluation, and treatment of vitamin D deficiency and insufficiency by promoting the standardized laboratory measurement of serum total 25-hydroxyvitamin D [25(OH)D]. VDSP promotes the standardized laboratory measurement of total 25(OH)D (a measure of vitamin D status) to improve clinical and public health practice worldwide.
|
Waterpipe- A Public Workshop
|
Meeting/ Workshop
|
FDA
|
NCI
|
The purpose of this workshop, held in March 2016, was to gather scientific information and stimulate discussion among scientists about waterpipes and waterpipe tobacco (hookah). It was intended to better inform FDA about these products through the exchange of scientific information, but is not intended to seek advice or consensus.
|
White House Interagency Committee on the Implementation of the US Strategy to Prevent and Respond to Gender-Based Violence Globally
|
Committee, Work group, Advisory group, or Task Force
|
ACF
|
NIDA, OD/DPCPSI/ORWH
|
Led by the Secretary of State and the Administration of the United States Agency for International Development, this working group was established by President Obama’s Executive Order 13623 - Preventing and Responding to Violence Against Women and Girls Globally. The working group’s charges were to address gender-based violence, which shall coordinate implementation of the Strategy by the executive departments and agencies that are members of the Working Group.
|
White House Office of National Drug Control Policy (ONDCP) Electronic Health Records (EHRs) Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, HRSA, IHS, OS, SAMHSA
|
NIDA, NIAAA, NIMH
|
This interagency working group coordinates initiatives across the U.S. Department of Health and Human Services to improve efforts to leverage meaningful use of electronic health records, health information technology, and related research and implementation activities as a means to improve quality, safety, and efficiency for substance use disorder research and treatment.
|
Work Group on Harmonizing Hemoglobinopathy Data Sets
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NLM, NCATS, NHLBI, NICHD, NIGMS, OD/OER
|
The mission of the Workgroup for Harmonizing Hemoglobinopathy Data Sets is to create a resource for federal programs and extramural communities to use in data systems which incorporate data elements in hemoglobinopathies. Specifically this entails establishing a Hemoglobinopathies Uniform Medical Language including: identifying specific goals and objectives for the kind of data that are required by these programs; case definitions for electronic data systems at all levels; consensus about conditions and data elements to be included; and differentiation between data needs for surveillance and for registries/biorepository.
|